Qing Liu, Ph.D., ASA Fellow’s Post

View profile for Qing Liu, Ph.D., ASA Fellow

Gene and Cell Therapies|Rare Disease|Agentic AI Prompt Engineering|AI Clinical Trials|AI Health|AI ALGO Agents|AWS Cloud Computing|Food as Medicine, Food Forest|Off-Road Camping

This is the part I of the article that describes confirmatory adaptive platform trial (CAPT) design for COVID-19 treatment development. In the Introduction, we provide generate description of ACTT, CATCO and SOLIDARITY trials which are emerging as confirmatory trials. We then describe key elements of CAPT design, followed by legal and regulatory requirement for confirmatory trial designs.

To view or add a comment, sign in

Explore content categories